Mediclinic International PLC (LON:MDC) had its target price decreased by Citigroup Inc. from GBX 790 ($10.42) to GBX 720 ($9.50) in a research report sent to investors on Wednesday, October 18th. Citigroup Inc. currently has a neutral rating on the stock.
Other analysts have also recently issued reports about the company. Jefferies Group LLC reduced their target price on Mediclinic International PLC from GBX 650 ($8.58) to GBX 550 ($7.26) and set an underperform rating on the stock in a report on Monday, September 25th. Credit Suisse Group restated a neutral rating on shares of Mediclinic International PLC in a report on Friday, July 21st. Morgan Stanley cut Mediclinic International PLC to an equal weight rating and cut their price target for the stock from GBX 825 ($10.89) to GBX 775 ($10.23) in a report on Thursday, June 29th. Finally, Investec cut Mediclinic International PLC to a hold rating and set a GBX 775 ($10.23) price target on the stock. in a report on Monday, June 26th. Two investment analysts have rated the stock with a sell rating and seven have given a hold rating to the company’s stock. Mediclinic International PLC has an average rating of Hold and a consensus price target of GBX 665.33 ($8.78).
Mediclinic International PLC (LON MDC) traded down 0.17% during midday trading on Wednesday, reaching GBX 591.50. 1,530,174 shares of the company traded hands. The stock’s market capitalization is GBX 4.36 billion. The firm has a 50 day moving average of GBX 669.11 and a 200-day moving average of GBX 743.61. Mediclinic International PLC has a 12 month low of GBX 587.50 and a 12 month high of GBX 941.50.
COPYRIGHT VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/10/28/mediclinic-international-plc-mdc-price-target-cut-to-gbx-720-by-analysts-at-citigroup-inc.html.
About Mediclinic International PLC
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.